About Bencure
Bencure is a company based in Jaipur (India). Bencure offers products and services including Thyrozest and Benglim.
- Headquarter Jaipur, India
- SectorsHealthcare
- Email••••••••
- Social Facebook
- Legal Name Bencure Life Sciences Private Limited
- Date of Incorporation 27 Mar, 2009
- Jurisdiction Jaipur, Rajasthan, India
- Annual Revenue₹26.1 Lakh
FY 2025 · -54% YoY
- Net Loss-₹14.1 Lakh
FY 2025 · -54% margin
- EBITDA-₹14 Lakh
FY 2025 · -53% margin
Associated legal entities of Bencure
Bencure operates through Bencure Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bencure Life Sciences Private Limited CIN U24232RJ2009PTC028552 | Active | 27 Mar 2009 | Jaipur, Rajasthan | ₹0.3 Cr | – | 4 | View details |
Products & Services of Bencure
Bencure offers a comprehensive portfolio of products and services, including Thyrozest and Benglim.
A formulation that is marketed for related health applications
A product that is sold for management in the specified field
Board of directors of Bencure Life Sciences Private Limited (Bencure)
Bencure Life Sciences Private Limited is the primary company behind Bencure. The board of Bencure Life Sciences Private Limited currently have 4 directors; the longest-serving is Sanjay Pansari, appointed in 2009. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Pansari DIN 02562640 | Director | 27 Mar 2009 | 17 yrs 6 mo | Bencure Life Sciences Private Limited |
| Ram Gopal Pansari DIN 02562642 | Director | 27 Mar 2009 | 17 yrs 6 mo | Bencure Life Sciences Private Limited |
| Annpurna Pansari DIN 02563654 | Director | 27 Mar 2009 | 17 yrs 6 mo | Bencure Life Sciences Private Limited |
| Savita Pansari DIN 06748388 | Director | 01 Jan 2014 | 12 yrs 9 mo | Bencure Life Sciences Private Limited |
Financials of Bencure
Figures of Bencure Life Sciences Private Limited, the primary company behind Bencure, for FY 2025. Revenue was ₹26.1 Lakh (-54% year on year). Net loss was -₹14.1 Lakh (-54% margin). EBITDA was -₹14 Lakh (-53% margin). Revenue has grown at a compounded annual rate of -19% over three years and -22% over five years.
- ₹26.1 LakhRevenue · FY 2025 · -54% YoY
- -₹14.1 LakhNet loss · -54% margin
- -₹14 LakhEBITDA · -53% margin
- ₹1 LakhPaid-up capital
- -19%Revenue CAGR, 3 years
- -22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bencure Life Sciences Private Limited are on its company page.
Detailed financial statements for Bencure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Bencure
10 companies that operate in the same segment as Bencure (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bencure
Bencure is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
The primary company behind Bencure, Bencure Life Sciences Private Limited, reported revenue of ₹26.1 Lakh for FY 2025, down 54% year on year.
Bencure Life Sciences Private Limited was established in 2010 and is recognized for the marketing and selling of branded formulations across various regions. A focus is placed on the fields of Cardiology and Diabetology, with operations centered in Hyderabad and extensions to states such as Rajasthan, Punjab, and Haryana. Quality healthcare products are provided at affordable prices, and commitments are made to deliver effective services. Presence is expanded in other states, ensuring accessibility for users. Overall, efforts are directed towards offering reliable healthcare solutions without promotional emphasis.
Bencure offers Thyrozest and Benglim.
Bencure operates through Bencure Life Sciences Private Limited.
The legal entities of Bencure currently have 4 directors, including Sanjay Pansari, Ram Gopal Pansari, Savita Pansari and others.